Magazine article from our research archive:
|
|
FDA Final Regulation on Early-Stage Clinical Drug Development
- Article from:
-
The Journal of Nuclear Medicine
- Article date:
-
September 1, 2008
- Author:
-
|
Copyright informationCopyright Society of Nuclear Medicine Sep 2008. Provided by ProQuest LLC. (Hide copyright information)
|
The U.S. Food and Drug Administration (FDA) on July 18 issued a final regulation designed to make early phase 1 clinical drug development "safe and efficient by enabling a phased approach to complying with current good manufacturing practice (CGMP) statutes and FDA investigational requirements," according to an administration press release. To facilitate this new approach, the regulation exempts most phase 1 investigational drugs from the requirements in 21 Code of Federal Regulations (CFR) part 211, The FDA will continue to exercise oversight of the manufacture of these drugs under its general statutory CGMP authority and through review of investigational new drug (IND) applications. A ...
Related newspaper, magazine, and journal articles:
|
New Guidance Addresses CGMPs For Investigational Drugs, Including...
Biopharm International;
February 1, 2006 ;
356 words
......need to be met for most investigational drugs manufactured for Phase I...controls during investigational drug development. The agency also says it...begin testing microdoses of investigational drugs before beginning traditional...
|
|
FDA RULE, COMPANION GUIDANCE MAKE EARLY STAGE CLINICAL DRUG DEVELOPMENT...
US Fed News Service, Including US State News;
July 18, 2008 ;
600 words
......Services' Food & Drug Administration issued...phase 1 clinical drug development safe and efficient...exempts most phase 1 investigational drugs from the requirements...earliest stages of drug development. This approach will...the manufacture of investigational ...
|
|
An overview of drug development in the United States and current...
Southern Medical Journal;
December 1, 2003 ;
700+ words
...Abstract: Drug development in the United...testing, have an Investigational New Drug Application...it as a New Drug Application...accelerate drug development and review of investigational drugs for life-threatening...participate in drug development. ...
|
|
Measures for measuring drug development
Pharmaceutical Executive;
July 1, 1996 ;
700+ words
...Drug development organizations are caught in a vise...market continually demand that drug development managers show them what development...more difficult to "show me" in drug development than in other types of organizations...
|
|
Pharsight Invited to Present on Model-Based Drug Development at 3rd Annual...
PR Newswire;
November 13, 2006 ;
523 words
......Present on the Value of Model-Based Drug Development and Co-Chair Speaker Symposium on...strategic services for optimizing clinical drug development, today announced that Helen Kastrissios...value of modeling and simulation in drug development, and will present a case study in...
|
|
Learn About the Outsourcing in Drug Development: The Contract CRO Market,...
Canadian Corporate News;
October 9, 2008 ;
700+ words
......available in its catalogue. Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition...reportlinker.com/p096408/Outsourcing-in-Drug-Development-The-Contract-CRO-Market-3rd-Edition...to increase revenues through faster drug development. By decreasing their in-house ...
|
|
Last chance to register for two day seminar on smarter drug development.
M2 Presswire;
October 26, 2005 ;
446 words
......register for two day seminar on smarter drug development(C)1994-2005 M2 COMMUNICATIONS LTD...the joint ICR/ABPI seminar Smarter Drug Development - Delivering the Science running from...challenges and opportunities in exploratory drug development and topics include: * European ...
|
|
PharmaSTART targets drug development.(News)
Chain Drug Review;
August 18, 2003 ;
617 words
......research institute to advance the drug development process. Stanford University; the...International to form PharmaSTART to speed drug development for the schools and small biotech...Biomedical Research. PharmaSTART will offer drug development and consultation services to help...
|
|
A new important intelligence tool called Daily Updates: Breaking...
M2 Presswire;
May 26, 2006 ;
700+ words
......Updates: Breaking Publications for the Drug Development Sector(C)1994-2006 M2 COMMUNICATIONS...Updates: Breaking Publications for the Drug Development Sector to their offering DailyUpdates...with breaking research articles and drug development news then you will be using one of...
|
See all results.
Or, try our
Advanced Search.
|